Fundraising Fox

Allay Therapeutics

San Jose, US · Founded 2016 · Delaware corporation · 3 known investors

allaytx.com ↗

Allay Therapeutics develops ultra-sustained analgesic products for post-surgical pain management. The company aims to reduce reliance on opioids through longer-lasting and safer pain relief solutions for patients and physicians.

BiotechHealthtechMedical Devicesin /allaytx@allaytx

Founders & leadership

AG
Adam GridleyExecutive Officer, Director
KH
Kristen HowellsExecutive Officer
JM
Josh MakowerDirector
HS
Hanson S. Gifford IIIDirector
TC
Tak CheungDirector
KD
Karun D. NagaExecutive Officer, Director
LR
Leighton ReadDirector
NV
Nicole VitulloDirector
MA
Michael A. CarusiDirector
TL
Tiffany LeDirector
PM
Paul McCreadieDirector
JL
J.C. LopezDirector

Investors · 3

Arboretum VenturesAnn Arbor · $5M – $15Mvia Paul McCreadie · board
Lightstone VenturesPortola Valleyvia Hanson S. Gifford · board
SGInnovateSingapore · $652K – $18M

Reported raises · per SEC filings

Form D private placements
▶$45MraisedFeb 2025 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leighton ReadDirector
  • Mark DeemDirector
  • Nicole VitulloDirector
  • Michael A. CarusiDirector
  • Tiffany LeDirector
  • Adam GridleyExecutive Officer, Director
  • Paul McCreadieDirector
  • J.C. LopezDirector
  • Anselm TanDirector
  • Kristen HowellsExecutive Officer
Offering amount
$60M
Amount sold
$45M
Minimum investment
$1
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$86.9MraisedDec 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tak CheungDirector
  • Josh MakowerDirector
  • Michael A. CarusiDirector
  • Paul McCreadieDirector
  • Nicole VitulloDirector
  • Adam GridleyExecutive Officer, Director
  • Leighton ReadDirector
  • Mark DeemDirector
Offering amount
$86.9M
Amount sold
$86.9M
Minimum investment
$1
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedJul 2021 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tak CheungDirector
  • Josh MakowerDirector
  • Mark DeemDirector
  • Leighton ReadDirector
  • Michael A. CarusiDirector
  • Adam GridleyExecutive Officer, Director
  • Karun D. NagaDirector
Offering amount
$18M
Amount sold
$15M
Minimum investment
$1
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.8MraisedFeb 2019 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Josh MakowerDirector
  • Hanson S. Gifford IIIDirector
  • Tak CheungDirector
  • Leighton ReadDirector
  • Michael A. CarusiDirector
  • Mark DeemExecutive Officer, Director
  • Karun D. NagaExecutive Officer, Director
Offering amount
$28.8M
Amount sold
$15.8M
Minimum investment
$1
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.